JP2022554357A5 - - Google Patents
Info
- Publication number
- JP2022554357A5 JP2022554357A5 JP2022526004A JP2022526004A JP2022554357A5 JP 2022554357 A5 JP2022554357 A5 JP 2022554357A5 JP 2022526004 A JP2022526004 A JP 2022526004A JP 2022526004 A JP2022526004 A JP 2022526004A JP 2022554357 A5 JP2022554357 A5 JP 2022554357A5
- Authority
- JP
- Japan
- Prior art keywords
- trna
- pharmaceutical composition
- nucleotide sequence
- expression vector
- gene product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025116258A JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962929428P | 2019-11-01 | 2019-11-01 | |
| US62/929,428 | 2019-11-01 | ||
| PCT/US2020/058415 WO2021087401A1 (en) | 2019-11-01 | 2020-10-30 | Methods and compositions for treating a premature termination codon-mediated disorder |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116258A Division JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022554357A JP2022554357A (ja) | 2022-12-28 |
| JP2022554357A5 true JP2022554357A5 (https=) | 2024-11-06 |
| JP7712270B2 JP7712270B2 (ja) | 2025-07-23 |
Family
ID=75715359
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526004A Active JP7712270B2 (ja) | 2019-11-01 | 2020-10-30 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| JP2025116258A Pending JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116258A Pending JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240148772A1 (https=) |
| EP (1) | EP4051291A4 (https=) |
| JP (2) | JP7712270B2 (https=) |
| KR (1) | KR20220155981A (https=) |
| CN (2) | CN115209902B (https=) |
| AU (1) | AU2020375040A1 (https=) |
| CA (1) | CA3156791A1 (https=) |
| WO (1) | WO2021087401A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
| KR102930465B1 (ko) | 2017-11-02 | 2026-02-25 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | ACE-tRNA를 이용한 유전 재할당을 통한 정지 코돈의 구조 방법 |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191233A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| MX2022012955A (es) * | 2020-04-14 | 2023-02-23 | Flagship Pioneering Innovations Vi Llc | Composiciones de trem y usos de las mismas. |
| AU2022269633A1 (en) * | 2021-05-05 | 2023-11-02 | Tevard Biosciences, Inc. | Methods and compositions for treating a premature termination codon-mediated disorder |
| JP2024538097A (ja) * | 2021-10-13 | 2024-10-18 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | Ｔｒｅｍ組成物及び使用方法 |
| AU2023255614A1 (en) | 2022-04-18 | 2024-10-24 | Vertex Pharmaceuticals Incorporated | Compositions and methods for enhancing aav therapy and decreasing tropism of aav to the liver. |
| WO2023220342A2 (en) * | 2022-05-13 | 2023-11-16 | Shape Therapeutics Inc. | Engineered tranfer rnas |
| EP4652272A1 (en) * | 2023-01-18 | 2025-11-26 | The Broad Institute Inc. | Prime editing-mediated readthrough of premature termination codons (pert) |
| WO2024155745A1 (en) * | 2023-01-18 | 2024-07-25 | The Broad Institute, Inc. | Base editing-mediated readthrough of premature termination codons (bert) |
| EP4442826A1 (en) | 2023-04-06 | 2024-10-09 | Universität Hamburg | Synthetic dna construct encoding transfer rna |
| WO2024226381A1 (en) * | 2023-04-28 | 2024-10-31 | University Of Rochester | A method of treating a premature translation termination codon n1n2n3 (ptc)-related disease by nonsense suppression in a subject |
| EP4458967A1 (en) | 2023-05-02 | 2024-11-06 | Universität Hamburg | Pharmaceutical composition comprising multiple suppressor transfer rnas |
| WO2025111506A1 (en) * | 2023-11-22 | 2025-05-30 | Tevard Biosciences, Inc. | Modified transfer rnas and methods of use |
| CN120418432A (zh) * | 2023-12-04 | 2025-08-01 | 睿愈(北京)生物医药科技有限公司 | 改善假尿苷修饰的密码子的通读的方法和组合物 |
| WO2026030209A1 (en) * | 2024-07-29 | 2026-02-05 | University Of Rochester | Use of decoding trnas to boost protein expression or function |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109112126B (zh) * | 2010-06-23 | 2024-06-14 | 库尔纳公司 | 通过抑制电压门控钠通道α亚基(SCNA)的天然反义转录物而治疗SCNA相关疾病 |
| MX365525B (es) * | 2011-09-06 | 2019-06-06 | Curna Inc | Compuestos que regulan la expresión de subunidades alfa de canales de sodio regulados por voltaje en enfermedades relacionadas con epilepsia mioclónica severa de la infancia. |
| WO2016149455A2 (en) * | 2015-03-17 | 2016-09-22 | The General Hospital Corporation | The rna interactome of polycomb repressive complex 1 (prc1) |
| CN110352244B (zh) * | 2016-09-01 | 2023-03-21 | ProQR治疗上市公司Ⅱ | 化学修饰的编辑rna的单链寡核苷酸 |
| KR102930465B1 (ko) * | 2017-11-02 | 2026-02-25 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | ACE-tRNA를 이용한 유전 재할당을 통한 정지 코돈의 구조 방법 |
-
2020
- 2020-10-30 CN CN202080090997.8A patent/CN115209902B/zh active Active
- 2020-10-30 CN CN202411915548.9A patent/CN119955780A/zh active Pending
- 2020-10-30 US US17/773,112 patent/US20240148772A1/en active Pending
- 2020-10-30 WO PCT/US2020/058415 patent/WO2021087401A1/en not_active Ceased
- 2020-10-30 CA CA3156791A patent/CA3156791A1/en active Pending
- 2020-10-30 EP EP20882711.3A patent/EP4051291A4/en active Pending
- 2020-10-30 JP JP2022526004A patent/JP7712270B2/ja active Active
- 2020-10-30 KR KR1020227018429A patent/KR20220155981A/ko not_active Ceased
- 2020-10-30 AU AU2020375040A patent/AU2020375040A1/en active Pending
-
2025
- 2025-07-10 JP JP2025116258A patent/JP2025148444A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022554357A5 (https=) | ||
| Nemunaitis et al. | A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients | |
| US11603540B2 (en) | Phagemid vector | |
| CN106471125B (zh) | 包括白蛋白结合部分的腺病毒 | |
| Zhang et al. | Immunostimulatory properties of chemotherapy in breast cancer: from immunogenic modulation mechanisms to clinical practice | |
| Yalvac et al. | AAV1. NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy | |
| KR20180120204A (ko) | 공기 매개 병원체 및 자극물질에 대한 보호용 조성물 및 방법 | |
| CN114729331A (zh) | 化学修饰的腺相关病毒 | |
| JP2024546641A5 (https=) | ||
| Gál et al. | Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury | |
| JP2022501055A5 (https=) | ||
| WO2021042944A1 (zh) | 肌肉靶向的微环dna基因治疗 | |
| Zhang et al. | Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model | |
| Li et al. | CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo | |
| Wang et al. | Role of mesenchymal stem cells in sepsis and their therapeutic potential in sepsis-associated myopathy | |
| Aljabali et al. | The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment | |
| EP4342993A1 (en) | Hpv infectious disease vaccine | |
| Marukawa et al. | Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma | |
| Li et al. | E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice | |
| CN118853767A (zh) | 一种新型溶瘤腺病毒载体及其构建方法和应用 | |
| Pan et al. | Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells | |
| Sato et al. | Extracellular vesicles derived from murine cementoblasts possess the potential to increase receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis | |
| WO2023133525A1 (en) | Optimized polynucleotides for protein expression | |
| Wang et al. | Adenovirus vector-mediated single chain variable fragments target the nucleocapsid protein of porcine epidemic diarrhea virus and protect against viral infection in piglets | |
| US20230023269A1 (en) | Inhibition of tnf-alpha by fibroblasts and fibroblast exosomes |